[Other] Confirmed tumor response by molecular subtype in patients with metastatic breast cancer: Sub-analysis from a phase 3 clinical study comparing oral paclitaxel and encequidar to IV paclitaxel.

John1Jr Post time Yesterday 23:35 | Show all posts |Read mode
This post will be closed automatically in 2026-06-07 23:35
Reward10points

journalㄩJournal of Clinical Oncology

AuthorsㄩGerardo Antonio Umanzor Funez; Hope S. Rugo; Jorge Umanzor; Francisco Barrios; Rosa Vasallo; M Chivalan; Suyapa A. Bejarano; Julio Roberto Ramirez; Luis Enrique Fein; Ruben Dario Kowalyszyn; Hui Wang; David Cutler

Published dateㄩ2021-5-20

DOIㄩ10.1200/jco.2021.39.15_suppl.1073

Article linkㄩhttps://doi.org/10.1200/jco.2021.39.15_suppl.1073

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    10


Daily Top Contributors

Return to the list